tirzepatide cardiovascular outcomes trial results july 2025 event risk assessment: a pre-specified meta-analysis Cardiovascular outcomes of semaglutide and
Description
Patients should use non-oral contraceptives or a backup method for 4 weeks after initiation and after each dose escalation
Completely different dose per unit
These results are transformative, often involving the loss of 50 to 100+ pounds depending on starting weight
Friedman is advising his patients to make a 10-minute followup appointment to discuss options
Liver and Kidney Function Blood tests may be recommended to check liver and kidney function before starting treatment, especially for patients with existing health conditions or regular medication use
Individual tolerance varies, so monitor personal responses
